Soluble urokinase Plasminogen Activator Receptor (suPAR) levels are predictive of COVID-19 severity: an Italian experience

BACKGROUND: The soluble urokinase Plasminogen Activator Receptor (suPAR) has been identified as a reliable marker of COVID-19 severity, helping in personalizing COVID-19 therapy. This study aims to evaluate the correlation between suPAR levels and COVID-19 severity, in relation to the traditional in...

Descripción completa

Detalles Bibliográficos
Autores principales: Infantino, Maria, Morena, Lorenza, Di Pietro, Massimo Antonio, Romanin, Benedetta, Cimolato, Barbara, Rocca, Beatrice Anna Luisa, Tunnera, Silvia, Modi, Giulia, Tilli, Marta, Grossi, Valentina, Lari, Barbara, Cerutti, Helena, Tesi, Giulia, Anrò, Valentina, Cartocci, Alessandra, Benucci, Maurizio, Veneziani, Francesca, Casprini, Patrizia, Manfredi, Mariangela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356594/
https://www.ncbi.nlm.nih.gov/pubmed/35944880
http://dx.doi.org/10.1016/j.clim.2022.109091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356594/
https://www.ncbi.nlm.nih.gov/pubmed/35944880
http://dx.doi.org/10.1016/j.clim.2022.109091

Ejemplares similares